Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-22-038228 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
24.90% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.88% · OPTIONAL · VALID
Operating cash generation 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.31% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
26.75% · CORE · VALID
Inventory pressure 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
15.37% · OPTIONAL · VALID
Gross margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
20.48% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
9.00% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.27% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.53% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 122.72%
Current 24.90%
Delta -97.81% Capex Intensity Increased
Previous 4.35%
Current 4.88%
Delta 0.53% Cash Generation Decreased
Previous 2.96%
Current 2.31%
Delta -0.64% Growth Increased
Previous 25.30%
Current 26.75%
Delta 1.45% Inventory Pressure Decreased
Previous 57.79%
Current 15.37%
Delta -42.42% Margin Increased
Previous 20.45%
Current 20.48%
Delta 0.03% Profitability Decreased
Previous 14.62%
Current 9.00%
Delta -5.62% R And D Intensity Increased
Previous 1.22%
Current 1.27%
Delta 0.05% Sbc Intensity Increased
Previous 0.52%
Current 0.53%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.